Advertisement
Singapore markets closed
  • Straits Times Index

    3,110.73
    +36.47 (+1.19%)
     
  • Nikkei

    32,307.86
    -550.45 (-1.68%)
     
  • Hang Seng

    16,334.37
    -11.52 (-0.07%)
     
  • FTSE 100

    7,554.47
    +40.75 (+0.54%)
     
  • Bitcoin USD

    43,910.71
    +775.29 (+1.80%)
     
  • CMC Crypto 200

    914.81
    +18.10 (+2.02%)
     
  • S&P 500

    4,604.37
    +18.78 (+0.41%)
     
  • Dow

    36,247.87
    +130.49 (+0.36%)
     
  • Nasdaq

    14,403.97
    +63.98 (+0.45%)
     
  • Gold

    2,020.80
    -25.60 (-1.25%)
     
  • Crude Oil

    71.26
    +1.92 (+2.77%)
     
  • 10-Yr Bond

    4.2450
    +0.1160 (+2.81%)
     
  • FTSE Bursa Malaysia

    1,441.97
    -0.88 (-0.06%)
     
  • Jakarta Composite Index

    7,159.60
    +24.98 (+0.35%)
     
  • PSE Index

    6,234.77
    -71.08 (-1.13%)
     

Halfords Shares Slump on Inflation Impact Warning

By Scott Kanowsky

Investing.com -- Shares in Halfords Group PLC (LON:HFD) slumped by more than 21% on Thursday, after the British cycling retailer warned "significant" cost inflation is having a negative impact on its financial performance.

The company added that it cannot forecast earnings for 2023 with "any degree of certainty," adding that the near-term outlook remains difficult due to an uptick in prices and a drop in demand for "higher ticket items."

"While rising inflation and declining consumer confidence will naturally present short-term challenges for any customer-facing business like ours, we remain confident in Halfords’ long-term growth prospects due to our service-led strategy and the enduring strength of our brand, people, products and services,” said Halfords chief executive Graham Stapleton in a statement.

In its preliminary full-year results, the group reported a 49.8% year-on-year rise in pre-tax profit, up to £96.6M. Revenue also increased by 6% to £1.37B.

Related Articles

Halfords Shares Slump on Inflation Impact Warning

Walgreens enters clinical trials business through new unit

Abbott halts EleCare output from plant at center of baby formula shortage